These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 2836826

  • 1. Pharmacological characterization of VIP receptors in human lung membranes.
    Robberecht P, Waelbroeck M, de Neef P, Camus JC, Coy DH, Christophe J.
    Peptides; 1988; 9(2):339-45. PubMed ID: 2836826
    [Abstract] [Full Text] [Related]

  • 2. [D-Phe4]peptide histidine-isoleucinamide ([D-Phe4]PHI), a highly selective vasoactive-intestinal-peptide (VIP) agonist, discriminates VIP-preferring from secretin-preferring receptors in rat pancreatic membranes.
    Robberecht P, Coy DH, De Neef P, Camus JC, Cauvin A, Waelbroeck M, Christophe J.
    Eur J Biochem; 1987 Jun 01; 165(2):243-9. PubMed ID: 3036504
    [Abstract] [Full Text] [Related]

  • 3. A new type of functional VIP receptor has an affinity for helodermin in human SUP-T1 lymphoblasts.
    Robberecht P, Waelbroeck M, De Neef P, Tastenoy M, Gourlet P, Cogniaux J, Christophe J.
    FEBS Lett; 1988 Feb 15; 228(2):351-5. PubMed ID: 2830146
    [Abstract] [Full Text] [Related]

  • 4. Interaction of vasoactive intestinal peptide (VIP) and N-terminally modified VIP analogs with rat pancreatic, hepatic and pituitary membranes.
    Robberecht P, Coy DH, De Neef P, Camus JC, Cauvin A, Waelbroeck M, Christophe J.
    Eur J Biochem; 1986 Aug 15; 159(1):45-9. PubMed ID: 3017717
    [Abstract] [Full Text] [Related]

  • 5. Properties of vasoactive-intestinal-peptide receptors and beta-adrenoceptors in the murine radiation leukemia-virus-induced lymphoma cell line BL/VL3.
    Abello J, Damien C, De Neef P, Tastenoy M, Hooghe R, Robberecht P, Christophe J.
    Eur J Biochem; 1989 Aug 01; 183(2):263-7. PubMed ID: 2547606
    [Abstract] [Full Text] [Related]

  • 6. Pharmacological characterization of the novel helodermin/VIP receptor present in human SUP-T1 lymphoma cell membranes.
    Robberecht P, De Neef P, Gourlet P, Cauvin A, Coy DH, Christophe J.
    Regul Pept; 1989 Aug 01; 26(2):117-26. PubMed ID: 2552509
    [Abstract] [Full Text] [Related]

  • 7. Characterization of binding sites for VIP-related peptides and activation of adenylate cyclase in developing pancreas.
    Le Meuth V, Farjaudon N, Bawab W, Chastre E, Rosselin G, Guilloteau P, Gespach C.
    Am J Physiol; 1991 Feb 01; 260(2 Pt 1):G265-74. PubMed ID: 1847591
    [Abstract] [Full Text] [Related]

  • 8. The activation of adenylate cyclase by pituitary adenylate cyclase activating polypeptide (PACAP) via helodermin-preferring VIP receptors in human SUP-T1 lymphoblastic membranes.
    Gourlet P, De Neef P, Woussen-Colle MC, Vandermeers A, Vandermeers-Piret MC, Robberecht P, Christophe J.
    Biochim Biophys Acta; 1991 Jul 22; 1066(2):245-51. PubMed ID: 1649637
    [Abstract] [Full Text] [Related]

  • 9. Pharmacology and molecular identification of vasoactive intestinal peptide (VIP) receptors in normal and cancerous gastric mucosa in man.
    Gespach C, Bawab W, Chastre E, Emami S, Yanaihara N, Rosselin G.
    Biochem Biophys Res Commun; 1988 Mar 15; 151(2):939-47. PubMed ID: 2831906
    [Abstract] [Full Text] [Related]

  • 10. Characterization of vasoactive intestinal peptide (VIP) receptors in mammalian lung.
    Dickinson KE, Schachter M, Miles CM, Coy DH, Sever PS.
    Peptides; 1986 Mar 15; 7(5):791-800. PubMed ID: 3025822
    [Abstract] [Full Text] [Related]

  • 11. PACAP and VIP receptors in rat liver membranes.
    Robberecht P, Gourlet P, Cauvin A, Buscail L, De Neef P, Arimura A, Christophe J.
    Am J Physiol; 1991 Jan 15; 260(1 Pt 1):G97-102. PubMed ID: 1846275
    [Abstract] [Full Text] [Related]

  • 12. Vasoactive intestinal peptide receptors in pancreas and liver. Structure-function relationship.
    Christophe J, Svoboda M, Waelbroeck M, Winand J, Robberecht P.
    Ann N Y Acad Sci; 1988 Jan 15; 527():238-56. PubMed ID: 2839079
    [Abstract] [Full Text] [Related]

  • 13. Analogues of VIP, helodermin, and PACAP discriminate between rat and human VIP1 and VIP2 receptors.
    Gourlet P, Vandermeers A, Van Rampelbergh J, De Neef P, Cnudde J, Waelbroeck M, Robberecht P.
    Ann N Y Acad Sci; 1998 Dec 11; 865():247-52. PubMed ID: 9928018
    [Abstract] [Full Text] [Related]

  • 14. Comparison of VIP-secretin receptors in rat and human lung.
    Christophe J, Chatelain P, Taton G, Delhaye M, Waelbroeck M, Robberecht P.
    Peptides; 1981 Dec 11; 2 Suppl 2():253-8. PubMed ID: 6123988
    [Abstract] [Full Text] [Related]

  • 15. Presence of vasoactive intestinal peptide receptors coupled to adenylate cyclase in rat lung membranes.
    Robberecht P, Chatelain P, De Neef P, Camus JC, Waelbroeck M, Christophe J.
    Biochim Biophys Acta; 1981 Nov 18; 678(1):76-82. PubMed ID: 6118184
    [Abstract] [Full Text] [Related]

  • 16. Effects of PHI on vasoactive intestinal peptide receptors and adenylate cyclase activity in lung membranes. A comparison in man, rat, mouse and guinea pig.
    Robberecht P, Tatemoto K, Chatelain P, Waelbroeck M, Delhaye M, Taton G, De Neef P, Camus JC, Heuse D, Christophe J.
    Regul Pept; 1982 Oct 18; 4(5):241-50. PubMed ID: 6294750
    [Abstract] [Full Text] [Related]

  • 17. Heart receptors for VIP, PHI and secretin are able to activate adenylate cyclase and to mediate inotropic and chronotropic effects. Species variations and physiopathology.
    Christophe J, Waelbroeck M, Chatelain P, Robberecht P.
    Peptides; 1984 Oct 18; 5(2):341-53. PubMed ID: 6089134
    [Abstract] [Full Text] [Related]

  • 18. Interaction of growth hormone-releasing factor (GRF) and 14 GRF analogs with vasoactive intestinal peptide (VIP) receptors of rat pancreas. Discovery of (N-Ac-Tyr1,D-Phe2)-GRF(1-29)-NH2 as a VIP antagonist.
    Waelbroeck M, Robberecht P, Coy DH, Camus JC, De Neef P, Christophe J.
    Endocrinology; 1985 Jun 18; 116(6):2643-9. PubMed ID: 2859987
    [Abstract] [Full Text] [Related]

  • 19. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
    Zawilska JB, Niewiadomski P, Nowak JZ.
    Gen Comp Endocrinol; 2004 Jun 18; 137(2):187-95. PubMed ID: 15158130
    [Abstract] [Full Text] [Related]

  • 20. Characterization and solubilization of vasoactive intestinal peptide receptors from rat lung membranes.
    Provow S, Veliçelebi G.
    Endocrinology; 1987 Jun 18; 120(6):2442-52. PubMed ID: 3032591
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.